Portal de investigación
Epigenetic alterations in disseminated neuroblastoma tumour cells: influence of TMS1 gene hypermethylation in relapse risk in NB patients.
Autores de IIS La Fe
Grupos
Abstract
Most neuroblastoma patients over 18 months of age at diagnosis present disseminated disease. The presence of neuroblastoma cells in bone marrow can be used to evaluate the response to treatment. It is possible that alterations in certain tumour cells might confer a selective advantage over tumour dissemination process, and probably be helpful in the clonal selection of tumour-specific cells that could originate metastasis.
Datos de la publicación
- ISSN/ISSNe:
- 0171-5216, 1432-1335
- Tipo:
- Article
- Páginas:
- 1415-1421
- PubMed:
- 20140741
- Factor de Impacto:
- 1,142 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY SPRINGER
Citas Recibidas en Web of Science: 15
Documentos
- No hay documentos
Filiaciones
Campos de Estudio
Cita
GRAU E,MARTINEZ F,ORELLANA C,CANETE A,YAÑEZ Y,OLTRA S,NOGUERA R,HERNANDEZ M,BERMÚDEZ JD,CASTEL V. Epigenetic alterations in disseminated neuroblastoma tumour cells: influence of TMS1 gene hypermethylation in relapse risk in NB patients. J. Cancer Res. Clin. Oncol. 2010. 136. (9):p. 1415-1421. IF:2,000. (3).